SARS-CoV-2 neutralizing antibody responses are more robust in patients with severe disease.

Pengfei Wang,Lihong Liu,Manoj S. Nair,Michael T. Yin,Yang Luo,Qian Wang,Ting Yuan,Kanako Mori,Axel Guzman Solis,Masahiro Yamashita,Ankur Garg,Lawrence J. Purpura,Justin C. Laracy,Jian Yu,Leemor Joshua-Tor,Joseph Sodroski,Yaoxing Huang,David D. Ho

SARS-CoV-2 neutralizing antibody responses are more robust in patients with severe disease.

2020

Pengfei Wang
Lihong Liu
Manoj S. Nair
Michael T. Yin
Yang Luo
Qian Wang
Ting Yuan
Kanako Mori
Axel Guzman Solis
Masahiro Yamashita
Ankur Garg
Lawrence J. Purpura
Justin C. Laracy
Jian Yu
Leemor Joshua-Tor
Joseph Sodroski
Yaoxing Huang
David D. Ho

We studied plasma antibody responses of 35 patients about 1 month after SARS-CoV-2 infection. Titers of antibodies binding to the viral nucleocapsid and spike proteins were significantly higher in ...

Keywords:

Titer
Virology
severe disease
severe acute respiratory syndrome coronavirus 2
Neutralizing antibody
Neutralization
Antibody
Viral nucleocapsid
in patient
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations